What are the treatment options to delay menstruation in women with polycystic ovary syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment to Delay Menstruation in Women with PCOS

For women with PCOS who need to delay their period, hormonal contraceptives (combined oral contraceptive pills) are the first-line treatment, with progesterone as an alternative for those with contraindications to estrogen-containing preparations 1.

Primary Treatment Approach

Hormonal Contraceptives (First-Line)

Combined oral contraceptive pills are recommended by multiple international guidelines as the primary treatment for managing menstrual irregularity in women with PCOS 1. These medications:

  • Regulate menstrual cycles effectively by providing hormonal control
  • Can be used continuously (skipping placebo pills) to delay or skip periods entirely
  • Provide endometrial protection against hyperplasia and cancer risk
  • Offer contraception as an added benefit
  • Use the same safety screening criteria as for the general population 1

Important consideration: Focus on low-dose estrogen preparations to minimize metabolic and thrombotic risks 2, 3. The type of progestin matters—formulations with less androgenic activity are preferred in PCOS patients 2.

Progesterone-Only Options (Alternative)

For women who cannot take combined hormonal contraceptives, progesterone therapy is specifically recommended to induce regular withdrawal bleeds in amenorrheic women with PCOS 1. This can be used:

  • As cyclical progestins for regular cycle control
  • As progestin-only pills for continuous use
  • Particularly useful when estrogen is contraindicated 4

Safety Screening Before Prescribing

Before initiating hormonal contraceptives, assess these specific risk factors 2, 5, 3:

  • Age and smoking status (increased arterial thrombosis risk)
  • Obesity and BMI (metabolic concerns)
  • Glucose tolerance status (prediabetes, diabetes, insulin resistance)
  • Blood pressure (hypertension screening)
  • Lipid profile (dyslipidemia)
  • Personal or family history of venous thromboembolism
  • Thrombophilia screening if indicated

Critical caveat: Women with severe insulin resistance and morbid obesity may have increased diabetes risk with oral contraceptives 5. However, current evidence shows that in young, nonsmoking women without vascular complications, the benefits typically outweigh risks 2.

Second-Line Options

Metformin

While metformin can improve menstrual cyclicity in PCOS 1, 6, 4, it is considered second-line for menstrual regulation and is most appropriate for:

  • Women with contraindications to hormonal contraceptives
  • Those with documented insulin resistance or dysglycemia
  • Patients who cannot tolerate hormonal options 6, 4

Metformin is less effective than hormonal contraceptives for directly controlling menstrual timing.

Practical Implementation

To delay a specific period: Use continuous combined oral contraceptive pills by skipping the placebo week and starting the next pack immediately. This is safe and effective in PCOS patients who have been appropriately screened 2, 3.

For long-term menstrual regulation: Extended-cycle or continuous hormonal contraceptive regimens can be prescribed, allowing women to have periods only 4 times yearly or less frequently.

Monitoring Requirements

Re-assess patients at follow-up visits for 3:

  • Weight changes and metabolic parameters
  • Blood pressure monitoring
  • Glucose tolerance (especially if baseline risk factors present)
  • Lipid profile changes
  • Any thrombotic symptoms or risk factors

The 2021 international guidelines emphasize that quality of life related to menstrual dysfunction is a primary consideration when evaluating treatment benefits 2, making hormonal contraceptives particularly valuable for women seeking menstrual control in PCOS.

References

Research

An Update on Contraception in Polycystic Ovary Syndrome.

Endocrinology and metabolism (Seoul, Korea), 2021

Research

Approach to the patient: contraception in women with polycystic ovary syndrome.

The Journal of clinical endocrinology and metabolism, 2015

Research

Menstrual Dysfunction in PCOS.

Clinical obstetrics and gynecology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.